[1] Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review [J]. Lance Oncol, 2011, 12(8): 815-824. [2] 苏立新, 张陈平, 胡永杰, 等. BDNF对唾液腺腺样囊性癌细胞株抗失巢凋亡能力和转移的影响 [J]. 中国口腔颌面外科杂志, 2007, 5(3): 207-210. [3] Guo D, Hou X, Zhang H, et al. More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells [J]. J Exp Clin Cancer Res, 2011, 30: 97. [4] Akdeniz O, Akduman D, Haksever M, et al. Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin [J]. Asian Pac J Cancer Prev, 2013, 14(9): 5301-5310. [5] Canel M, Serrels A, Frame MC, et al. E-cadherin-integrin crosstalk in cancer invasion and metastasis [J]. J Cell Sci, 2013, 126(Pt 2): 393-401. [6] Chen C, Wei Y, Hummel M, et al. Evidence for epithelial- mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma [J]. PLoS One, 2011, 6(1): e16466. [7] Kupferman ME, Jiffar T, El-Naggar A, et al. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma [J]. Oncogene, 2010, 29(14): 2047-2059. [8] Kowalski PJ, Paulino AF. Perineural invasion in adenoid cystic carcinoma: its causation/promotion by brain-derived neurotrophic factor [J]. Hum Pathol, 2002, 33(9):933-936. [9] 苏立新, 张陈平, 胡永杰, 等. BDNF和TrkB在唾液腺腺样囊性癌中的表达及意义 [J]. 中国口腔颌面外科杂志, 2006, 4(5): 330-335. [10] Huang YT, Lai PC, Wu CC, et al. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells [J]. Int J Oncol, 2010, 36(6): 1469-1476. [11] Au CW, Siu MK, Liao X, et al. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - effect on cell migration, angiogenesis and clinical outcome [J]. Cancer Lett, 2009, 281(2): 151-161. [12] Fujikawa H, Tanaka K, Toiyama Y, et al. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells [J]. J Gastroenterol,2012, 47(7): 775-784. [13] Wells A, Yates C, Shepard CR, et al. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas[J]. Clin Exp Metastasis, 2008, 25(6): 621-628. [14] Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression [J]. J Mammary Gland Biol Neoplasia,2010,15(2): 117-134. [15] Paredes J, Figueiredo J, Albergaria A, et al. Epithelial E- and P-cadherins: role and clinical significance in cancer [J]. Biochim Biophys Acta, 2012, 1826(2): 297-311. [16] Zhao Z, Ge J, Sun Y, et al. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis [J]. Oral Oncol, 2012, 48(9): 761-767. |